Literature DB >> 412502

Thymidine concentrations in serum and urine of different animal species and man.

H Nottebrock, R Then.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 412502     DOI： 10.1016/0006-2952(77)90271-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  37 in total

1.  Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe.

Authors:  Dean O Campbell; Shahriar S Yaghoubi; Ying Su; Jason T Lee; Martin S Auerbach; Harvey Herschman; Nagichettiar Satyamurthy; Johannes Czernin; Arnon Lavie; Caius G Radu
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

Review 2.  [18F]FLT-PET in oncology: current status and opportunities.

Authors:  Lukas B Been; Albert J H Suurmeijer; David C P Cobben; Pieter L Jager; Harald J Hoekstra; Philip H Elsinga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12       Impact factor: 9.236

3.  Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model.

Authors:  José M Entenza; Andreas Haldimann; Marlyse Giddey; Sergio Lociuro; Stephen Hawser; Philippe Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

4.  Tuberculosis and trimethoprim-sulfamethoxazole.

Authors:  Pierre Forgacs; Nancy L Wengenack; Leslie Hall; Sarah K Zimmerman; Mark L Silverman; Glenn D Roberts
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

5.  Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs.

Authors:  Johannes Zander; Silke Besier; Hanns Ackermann; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

6.  Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.

Authors:  Seung Jin Lee; Jeong Seok Yeo; Haeng Jung Lee; Eun Jung Lee; Seog Young Kim; Se Jin Jang; Jong Jin Lee; Jin-Sook Ryu; Dae Hyuk Moon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

Review 7.  Fluorinated tracers for imaging cancer with positron emission tomography.

Authors:  Olivier Couturier; André Luxen; Jean-François Chatal; Jean-Philippe Vuillez; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-06       Impact factor: 9.236

8.  Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors.

Authors:  Rolf F Barth; Weilian Yang; Gong Wu; Michele Swindall; Youngjoo Byun; Sureshbabu Narayanasamy; Werner Tjarks; Kevin Tordoff; Melvin L Moeschberger; Staffan Eriksson; Peter J Binns; Kent J Riley
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

9.  Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas.

Authors:  Michelle S Bradbury; Dolores Hambardzumyan; Pat B Zanzonico; Jazmin Schwartz; Shangde Cai; Eva M Burnazi; Valerie Longo; Steven M Larson; Eric C Holland
Journal:  J Nucl Med       Date:  2008-02-20       Impact factor: 10.057

10.  Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.

Authors:  B P Goldstein; I F Ripamonti; G Bolzoni; G Carniti; V Arioli
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.